Mekeel K L, Tang W, Kachnic L A, Luo C M, DeFrank J S, Powell S N
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Oncogene. 1997 Apr 17;14(15):1847-57. doi: 10.1038/sj.onc.1201143.
Using a plasmid substrate which integrates into the genome, we determined that the rate of homologous recombination was suppressed by p53. Human tumor cell lines, mutant or null for p53 had recombination rates 10000-times greater than primary fibroblasts. When isogenic cell pairs from tumor cells or primary fibroblasts were compared, differing only in one genetic change which inactivated p53, the recombination rate increased > 100-fold. Functional inactivation of p53 by dominant mutant p53, by large T antigen of SV40 virus, by E6 protein of human papilloma virus, or by genetic deletion led to the same result. Our results suggest that p53 suppresses spontaneous homologous recombination, and that p53 is not required for recombination to proceed. The mechanism of recombination suppression may be related to the reported association of p53 with Rad 51, but the functional consequences of this association are not yet established. It is suggested that suppression of homologous recombination is the means by which p53 maintains genetic stability.
利用一种整合到基因组中的质粒底物,我们确定同源重组率受到p53的抑制。p53突变或缺失的人类肿瘤细胞系的重组率比原代成纤维细胞高10000倍。当比较来自肿瘤细胞或原代成纤维细胞的同基因细胞对时,它们仅在一个使p53失活的基因变化上有所不同,重组率增加了100倍以上。由显性突变型p53、SV40病毒的大T抗原、人乳头瘤病毒的E6蛋白或基因缺失导致的p53功能失活均产生了相同的结果。我们的结果表明,p53抑制自发同源重组,并且重组过程不需要p53。重组抑制机制可能与报道的p53与Rad 51的关联有关,但这种关联的功能后果尚未确定。有人提出,同源重组的抑制是p53维持遗传稳定性的方式。